Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
Intercytex (Cambridge, U.K.) said ICX-PRO met the primary endpoint of complete wound closure at 12 weeks in a U.K. Phase IIb trial to treat venous leg ulcers. In the open-label trial, 44% of patients ...
